Development of strategic brands Audited

Global sales of most of our strategic brands developed well in 2009. Sales of Kytta® grew 33% to € 19 million, Bion®3 sales increased by 10% to € 49 million, and sales of Femibion® rose 29% to € 33 million. Owing to unfavorable exchange rate movements, sales by Seven Seas fell 9.5% to € 38 million. Nasivin® registered a decline of 9% to € 42 million, which was attributable to the weakness of the Russian market, among other things.

Top five brands by sales in 2009

Consumer Health Care – Top five brands by sales in 2009 (pie chart)